Axonics Modulation Technologies

AXNX64

$69.15arrow_drop_down0.14%-$0.10

AXNX64

$69.15

arrow_drop_down0.14%-$0.10

Performance History

Key Stats
Open	$69.26
Prev. Close	$69.25
EPS	-0.02
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	68.92	69.27
52 Week Range	48.30	69.68

Ratios







EPS	-0.02

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Axonics Modulation Technologies (AXNX)

Axonics Modulation Technologies Inc (AXNX) is a medical technology company that specializes in the design, development, and commercialization of innovative solutions for patients with urinary and fecal dysfunction. The company's key product is the Axonics Sacral Neuromodulation System, a miniaturized implantable device that helps to restore normal bladder and bowel function in patients suffering from various urological and gastrointestinal conditions. This system utilizes a rechargeable and long-lasting battery, allowing patients to experience long-term symptom relief and improved quality of life.

In terms of its stock price history, AXNX has shown steady growth since its initial public offering in 2018. The stock has consistently performed well, reflecting the market's confidence in the company's innovative technology and growth potential. Investors have been attracted to AXNX due to its promising product pipeline, strong financial performance, and positive market outlook. As a result, the company has seen a significant increase in its market capitalization, solidifying its position as a leading player in the medical technology industry.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Raymond W. Cohen
Headquarters: Irvine
Employees: 610
Exchange: NASDAQ

add Axonics Modulation Technologies to watchlist

Keep an eye on Axonics Modulation Technologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Axonics Modulation Technologies (AXNX) stock price performance year to date (YTD)?

As of the latest data, Axonics Modulation Technologies (AXNX) has a year-to-date price change of 15.81%. Over the past month, the stock has experienced a price change of 0.32%. Over the last three months, the change has been 2.11%. Over the past six months, the figure is 1.3%. Looking at a longer horizon, the five-year price change stands at 123.79%.

help

What is Axonics Modulation Technologies 's (AXNX) price per share?

The current price per share for Axonics Modulation Technologies (AXNX) is $69.15. The stock has seen a price change of -$0.1 recently, indicating a -0.14% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Axonics Modulation Technologies (AXNX)?

For Axonics Modulation Technologies (AXNX), the 52-week high is $69.68, which is 0.77% from the current price. The 52-week low is $48.3, the current price is 43.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Axonics Modulation Technologies (AXNX) a growth stock?

Axonics Modulation Technologies (AXNX) has shown an average price growth of 0.41% over the past three years. It has received a score of 59 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Axonics Modulation Technologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is Axonics Modulation Technologies (AXNX) a profitable company?

Axonics Modulation Technologies (AXNX) has a net income of -$6.09M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 72.46% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 5.53% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $366.38M, with a revenue growth rate of 33.86%, providing insight into the company's sales performance and growth. The gross profit is $265.49M. Operating income is noted at -$4.71M. Furthermore, the EBITDA is $29.12M.

help

What is the market capitalization of Axonics Modulation Technologies (AXNX)?

Axonics Modulation Technologies (AXNX) has a market capitalization of $3.53B. The average daily trading volume is 330K, indicating the stock's liquidity and investor engagement.